Home > PE Ratio > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of BAFNA PHARMACEUTICALS is 18.48.

Share Price ₹87.8Apr 26,2024
Market Cap ₹208.1 Cr
Earnings-TTM₹11.3 CrTTM-Standalone Results
Price/Earnings18.48xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of BAFNA PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BAFNA PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹208.1 Cr] as on Apr 26,2024

(/) Earnings [ ₹11.3 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 18.48x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BAFNA PHARMACEUTICALS , the investors are currently willing to pay 18.48 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BAFNA PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BAFNA PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of BAFNA PHARMACEUTICALS


PE Ratio Performance Analysis for BAFNA PHARMACEUTICALS

- BAFNA PHARMACEUTICALS 's latest p/e ratio is 18.48x.

- BAFNA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 26.11x.

- BAFNA PHARMACEUTICALS 's operated at median p/e ratio of 17.24x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BAFNA PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 57.59x.

- BAFNA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0x.


How does BAFNA PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BAFNA PHARMACEUTICALS 11.2618.48208.1
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.11360,920.0
CIPLA LTD3,744.0330.39113,794.0
DR REDDYS LABORATORIES LTD5,209.4020.02104,316.0
ZYDUS LIFESCIENCES LTD2,954.2032.2995,380.9
DIVIS LABORATORIES LTD1,382.9777.27106,860.0
MANKIND PHARMA LTD1,743.3054.4294,869.4
TORRENT PHARMACEUTICALS LTD1,494.0060.9591,057.0
LUPIN LTD1,809.7440.6973,642.4
AUROBINDO PHARMA LTD2,777.8923.8666,278.5
ABBOTT INDIA LTD1,145.5847.9854,961.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BAFNA PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.48x
Max industry PE 77.27x
Median industry PE 40.11x
Average industry PE 40.59x



You may also like the below Video Courses